United States: Amicus Briefs Not So Friendly to California Supreme Court's Dreadful BMS Personal Jurisdiction Decision

Last Updated: November 24 2016
Article by Stephen J. McConnell

We do a lot of grousing on this blog, but we acknowledge that there is much for which we should be thankful. This legal business permits us to keep our minds lively and our fingernails clean. Even the rotten decisions aren't totally awful; they force us to stay busy, offer a fine target for snark, and it is beyond glorious when logic and justice eventually triumph and eradicate the offending ruling. (We're looking at you Conte. Your days are numbered.)

The Supreme Court's decision in Bauman is an example of the beneficent arc of history. After decades of doctrinal incoherence on personal jurisdiction, under which a large corporation could pretty much be sued anywhere for anything, SCOTUS restored common sense by holding that a court could exercise general personal jurisdiction over a corporation only if that corporation was "at home" in that jurisdiction – which pretty much was limited to the place of incorporation or principal place of business. We blogged about Bauman more than once, but you can start here. Around the same time as Bauman, SCOTUS issued the Walden v. Fiore opinion, which limited specific jurisdiction over corporations to cases where the corporation's conduct targeted the jurisdiction and gave rise to the action in that jurisdiction. Simple, right?

Wrong, says the California Supreme Court. Bristol-Myers Squibb Co. v. Superior Court was a classic exercise in mass tort litigation tourism, as plaintiff lawyers cobbled together a group of plaintiffs who claimed that they had been injured by ingesting Plavix. Out of 678 plaintiffs, only 86 lived in California. The other 592 plaintiffs neither lived in California nor sustained any injury there. It is not as if those plaintiffs knocked back Plavix after enduring the scary experience of Space Mountain at Disneyland or the Angels' ineptitude at the Big A in Anaheim. None of the Plavix was manufactured in California. Clearly, the plaintiff lawyers had engaged in transparent forum-shopping, hoping that their non-California plaintiffs would benefit from pro-plaintiff California jurors and rulings.

And now here comes another one of those pro-plaintiff rulings. The California Supreme Court admitted that Bauman meant that general personal jurisdiction could not extend to BMS, which had the wisdom not to incorporate or locate its principal place of business in California. Adios to all those non-California plaintiffs, right? Wrong again, says the California Supreme Court, which, in a 4-3 decision, expanded specific jurisdiction to the point where it pretty much gobbles up general jurisdiction. Specific jurisdiction extends to a defendant when the plaintiff's claim arose from or related to the defendant's conduct. That obviously works for the California plaintiffs. How does it work for the non-Californians? That's the right question. The California Supreme Court came up with the wrong answer. It held that "[a] claim need not arise directly from the defendant's forum contacts in order to be sufficiently related to the contact to warrant the exercise of specific jurisdiction." That holding seems as wrong as can be. But if not "directly," what is enough? The California Supreme Court said it was enough that Plavix marketing throughout the nation was the same, plus BMS had employees and facilities in California. Huh? There is also a flavor of pendent jurisdiction in the court's holding. Since you, BMS, have to be in California anyway to defend against the claims of Californians, why not stay a while, have some avocadoes and almonds, and take on all those Illini, Hoosiers, Texans, etc. while you're at it? Either that is part and parcel of the court's theory, or maybe the court would have smiled on a case brought only by non-Californians. The fact that we are not sure that is not so is testament to the California Supreme Court's penchant for result-oriented lunacy.

Look, the California opinion was a blatant instance of juridical overreaching, if not flat-out defiance. We did not enjoy reading it. But we did enjoy blogging about the opinion's many howlers – here and here for example. Our harsh view of the California Supreme Court's 'reasoning' was almost as excoriating as the dissent opinion.

This week we enjoyed reading the amicus briefs recently filed in support of the petition for certiorari filed, which asked SCOTUS to correct the California error. You can find the briefs on the wonderful SCOTUS blog. One of those briefs was filed by one of our clients, so we won't say anything about that one, except to remark that it is just as excellent and wonderful and helpful as the client's fine products and stellar in-house lawyers. Let's talk briefly about the briefs filed by (1) the Chamber of Commerce and American Tort Reform Association (ATRA), (2) Pharmaceutical Research and Manufacturers of America (PhRMA), (3) the Product Liability Advisory Council (PLAC), and (4) the Washington Legal Foundation (WLF). As one would expect, these briefs make many of the same points, but they also differ slightly in their emphases.

Chamber of Commerce/ATRA

This brief makes the point that, contrary to the California Supreme Court's position, there must be a direct connection between the defendant's conduct and the plaintiff's cause of action for specific jurisdiction to lie. The California Supreme Court's sliding scale approach – the greater the corporate defendant's presence in California, the less connection to the cause of action is required – is a mess that finds support precisely nowhere. Nothing in SCOTUS precedents "suggests that mere parallelism between a defendant's in-State conduct and the conduct that allegedly caused an out-of-State injury is enough to create specific jurisdiction over the out-of-State claim." Moreover, the California Supreme Court's ruling breeds uncertainty. Companies cannot calibrate their actions and sales to possible litigation exposure in California. In for a penny, in for billions. Instead, California has essentially blessed forum shopping by plaintiff lawyers. That approach not only guarantees further crowding of the California court system, but it also wounds federalism. States might want to see to the vindication of their own citizens' claims, but now those claims will head to California and other heckholes.


The California standard is "formless." It provides no real guidance. Instead, it turns California into a "magnet" – a polite word for heckhole, which is, in turn, a polite word for what we really mean. The brief likens California to what has been going on in St. Louis, where local judges seem almost gleefully eager to prove their proficiency at home cooking for the local plaintiffs' bar. PhRMA's first argument heading is nothing short of brilliant: "WHETHER CALIFORNIA COURTS CONSTITUTIONALLY MAY SERVE AS NATIONAL COURTS FOR RESOLVING CLAIMS OF OUT-OF-STATE PLAINTIFFS IS A PROFOUND AND RECURRING QUESTION." Like all artfully phrased questions, it answers itself. The brief includes fascinating statistics, such as that in 2900+ cases recently filed in LA and San Francisco counties against pharmaceutical companies, there were over 25,000 plaintiffs, with only 10.1% residing in California. PhRMA also decries the difficulty in bringing live treating physician testimony for out of state plaintiffs (though that would also usually be true if the case was filed in the defendant's home state, and no one doubts jurisdiction there). The PhRMA brief makes good use of the dissent in the California case, especially the observation that the majority opinion "expands specific jurisdiction to the point that, for a large category of defendants, it becomes indistinguishable from general jurisdiction."


This brief does a marvelous job of tracing the origin of the doctrinal confusion to Helicopteros Nacionales de Colombia, S.A v. Hall, 466 U.S. 408 (1984), where SCOTUS was unclear on what "arise from" and "relating to' mean, or whether there is any difference between them. SCOTUS had the chance to clear things up in Shute v. Carnival Cruise Lines, 499 U.S. 585 (1991), but went off on another issue. Since SCOTUS created this ambiguity, it is up to SCOTUS to clarify. As with several of these amicus briefs, PLAC makes the point that the California ultra-expansive view of "relating to" means an utter lack of predictability for corporations as to where they might get sued. (This argument probably does have practical significance. Then again, we wonder whether, in a way, crummy rulings can create predictability. Isn't it becoming predictable that plaintiff lawyers will, by hook or crook, find ways to sue in heckholes such as California, Madison County, and St. Louis? It reminds us of search and seizure law, where court decisions themselves can influence expectations of privacy.). PLAC takes a whack at the California court's reliance on the nationwide similarity of the product marketing. Regularity regimes impose a certain degree of uniformity, and the "nationwide advertising" rationale "is potentially far-reaching given the ubiquitous use of social media and the internet today by companies of all sizes." Moreover, the California "sliding scale" for measuring whether a "substantial connection" only "compounds the indeterminacy and unpredictability." That sliding scale ends up being a fig leaf covering up a blessing of plaintiff forum shopping. PLAC also demonstrates that this personal jurisdiction issue is recurring, important (often dispositive), and implicates concerns over whether other countries will reciprocate with similarly absurd jurisdictional claims.


This brief convincingly shows that the California decision undermines Bauman and is inconsistent with Walden. In Walden, SCOTUS referred to jurisdiction arising from the defendant's "suit-related conduct." Any large company in America "that aspires to conduct business on a nationwide basis has no choice but to conduct business in California" – probably lots of it. The "limitless" nature of specific jurisdiction in the BMS case ensures forum-shopping and prevents companies from being able to "structure their conduct with some minimum assurance as to where that conduct will and will not render them liable to suit." Finally, the BMS case is well set up for SCOTUS review because the issues are clear and the facts are uncontested.

All in all, these briefs are superb. Unlike the California decision, they actually make sense. Unlike the California decision, they respect SCOTUS precedent. We are grateful for the fine work that went into these briefs, and will be even more grateful when SCOTUS sets things aright.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.